Skip to content

Sorafenib

Sorafenib (Nexavar) is a targeted cancer medicine used to treat advanced liver, kidney, and thyroid cancers. This catalogue lists Nexavar 200mg tablets.

Nexavar

Hepatocellular Carcinoma, Renal Cell Carcinoma

200mg

Sorafenib tablets for liver and kidney cancer. It blocks the growth of new blood vessels that tumours need to grow.

From$5.24/ tabletView

Key points

  • Sorafenib is a kinase inhibitor, a type of targeted cancer medicine that blocks proteins cancer cells rely on to grow.
  • Nexavar is the originator brand from Bayer; the 200mg tablet is the only form listed here.
  • Common side effects include fatigue, diarrhoea, and skin reactions; tell your doctor if these become troublesome.

What Sorafenib is used for

Sorafenib is listed for three advanced cancers: Hepatocellular Carcinoma, Renal Cell Carcinoma, and differentiated thyroid carcinoma. It is part of the Oncology Support category.

Further reading